Format

Send to:

Choose Destination
See comment in PubMed Commons below
Mol Genet Metab. 2011 Sep-Oct;104(1-2):7-9. doi: 10.1016/j.ymgme.2011.07.008. Epub 2011 Jul 19.

Personalized medicine for individuals with Down syndrome.

Author information

  • 1Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, CO 80045, USA. linda.mccabe@ucdenver.edu

Abstract

As the cost of whole genome analysis decreases, we have the opportunity to explore the interactions of various gene changes in an individual that lead to their particular phenotype. This will provide the ability to move from the epidemiologic study of groups, in which, the individuals are treated collectively and homogenously, to personalized medicine, and a model in which the individual is recognized and treated as a distinct entity. We will be applying personalized medicine to individuals with Down syndrome in order to understand and develop biomarkers for increased risk of co-morbidities. Personalized medicine will change the "culture of intractability" of Down syndrome.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21807541
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk